Interpreting Key Trials
The Hope Study
Ramipril lowered cardiovascular risk, but vitamin E did not
Byrom J. Hoogwerf, MD and James B. Young, MD
Cleveland Clinic Journal of Medicine April 2000, 67 (4) 287-293;
Byrom J. Hoogwerf
Department of Endocrinology, Director, Internal Medicine Residency Program, Cleveland Clinic; investigator, Heart Outcomes Prevention Evaluation (HOPE) study
James B. Young
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, Cleveland Clinic; member, steering committee, Heart Outcomes Prevention Evaluation (HOPE) study

Article Information
vol. 67 no. 4 287-293
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 1, 2000.
Copyright & Usage
Copyright © 2000 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 67, Issue 4
1 Apr 2000
The Hope Study
Byrom J. Hoogwerf, James B. Young
Cleveland Clinic Journal of Medicine Apr 2000, 67 (4) 287-293;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension
- Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
- Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR





